Leukemia Clinical Trials in Chicago

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Recruiting
  • Myelofibrosis
  • +13 more
  • Phoenix, Arizona
  • +54 more
2022-03-04
Mar 4, 2022
P
Active, not recruiting
  • Leukemia
  • +2 more
  • inotuzumab ozogamicin-dose level 2
  • Inotuzumab ozogamicin-dose level 1
  • Los Angeles, California
  • +45 more
2022-03-09
Mar 9, 2022
C
Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
2022-03-07
Mar 7, 2022
C
Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
2022-03-03
Mar 3, 2022
I
Recruiting
  • Leukemia
  • Birmingham, Alabama
  • +107 more
2022-02-22
Feb 22, 2022
R
Withdrawn
  • Leukemia
  • recombinant interferon alfa
  • +7 more
  • Chicago, Illinois
  • +3 more
2021-10-06
Oct 6, 2021
N
Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
2021-09-03
Sep 3, 2021
A
Active, not recruiting
  • Leukemia
  • Lymphoma
  • rituximab
  • +7 more
  • Duarte, California
  • +24 more
2021-08-16
Aug 16, 2021
A
Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +175 more
2021-08-16
Aug 16, 2021
A
Active, not recruiting
  • Leukemia
  • +2 more
  • laboratory biomarker analysis
  • San Diego, California
  • +50 more
2021-08-16
Aug 16, 2021
A
Active, not recruiting
  • Leukemia
  • fluorescence in situ hybridization
  • +6 more
  • San Diego, California
  • +34 more
2021-07-19
Jul 19, 2021
A
Active, not recruiting
  • Leukemia
  • DNA analysis
  • +3 more
  • San Diego, California
  • +160 more
2021-07-19
Jul 19, 2021
D
Active, not recruiting
  • Acute Myeloid Leukemia
  • Leukemia
  • Gainesville, Florida
  • +243 more
2021-06-08
Jun 8, 2021
S
Completed
  • Leukemia
  • Duarte, California
  • +19 more
2021-06-07
Jun 7, 2021
R
Unknown status
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
2021-04-20
Apr 20, 2021
U
Completed
  • Leukemia
  • +3 more
  • Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)
  • +4 more
  • Chicago, Illinois
    The University of Chicago
2021-01-08
Jan 8, 2021
E
Completed
  • Leukemia
  • sargramostim
  • +7 more
  • Birmingham, Alabama
  • +98 more
2020-10-23
Oct 23, 2020
N
Completed
  • Leukemia
  • Alemtuzumab
  • Rituximab
  • Chicago, Illinois
    Northwestern University, Northwestern Medical Faculty Foundation
2020-10-15
Oct 15, 2020
A
Active, not recruiting
  • Leukemia
  • DNA analysis
  • +7 more
  • Mountain View, California
  • +76 more
2020-10-08
Oct 8, 2020
A
Terminated
  • Leukemia
  • rituximab
  • fludarabine phosphate
  • Anniston, Alabama
  • +386 more
2020-04-09
Apr 9, 2020
A
Completed
  • Leukemia
  • DNA analysis
  • +6 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
2020-02-19
Feb 19, 2020